E-cadherin expression predicts clinical outcome in carcinoma in situ of the urinary bladder

By Shariat S.F.   Pahlavan S.   Baseman A.G.   Brown R.M.   Green A.E.   Wheeler T.M.   Lerner S.P.  

Urology, Vol. 57, Iss. 1, 2001-01 ,pp. : 60-65

Elsevier

Access to resources Recommend Favorite

p53 and ki67 Expression as Prognostic Factors for Cancer-Related Survival in Stage T1 Transitional Cell Bladder Carcinoma

By Rodrguez-Alonso A.   Pita-Fernandez S.   Gonzalez-Carrero J.   Nogueira-March J.L.  

European Urology, Vol. 41, Iss. 2, 2002-02 ,pp. : 182-189

Elsevier

Access to resources Recommend Favorite

The significance of p53 and bcl-2 overexpression and other prognostic factors in transitional cell carcinoma of the bladder

By Touloupidis Stavros   Fatles Georgios   Kalaitzis Christos   Giatromanolaki Alexandra   Sivridis Eythimyos   Simopoulos Konstantinos   Rombis Vassilios  

International Urology and Nephrology, Vol. 38, Iss. 2, 2006-06 ,pp. : 231-236

Springer Publishing Company

Access to resources Recommend Favorite

Prognostic value of p53 nuclear accumulation and histopathologic features in T1 transitional cell carcinoma of the urinary bladder

By Shariat S.F.   Weizer A.Z.   Green A.   Laucirica R.   Frolov A.   Wheeler T.M.   Lerner S.P.  

Urology, Vol. 56, Iss. 5, 2000-11 ,pp. : 735-740

Elsevier

Access to resources Recommend Favorite

Association of p53 and p21 expression with clinical outcome in patients with carcinoma in situ of the urinary bladder

By Shariat S.F.   Kim J.   Raptidis G.   Ayala G.E.   Lerner S.P.  

Urology, Vol. 61, Iss. 6, 2003-06 ,pp. : 1140-1145

Elsevier

Access to resources Recommend Favorite